 Your new post is loading...
Your new post is loading...
|
Scooped by
HAS-veille
August 7, 2023 4:52 AM
|
Recombinant zoster vaccine (RZV) is recommended in the US for prevention of herpes zoster (HZ) in adults aged ≥50 years. Vaccination rates remain subo…
|
|
Scooped by
HAS-veille
August 7, 2023 4:50 AM
|
The Immunization Agenda 2030 (IA2030) Impact Goal 1.1. aims to reduce the number of future deaths averted through immunization in the next decade. To …
|
|
Scooped by
HAS-veille
August 7, 2023 4:33 AM
|
In August 2021, France enacted a COVID-19 certificate requirement (vaccination/recovery/test) to access specific services, with mandates for professio…
|
|
Scooped by
HAS-veille
August 7, 2023 4:26 AM
|
This paper investigates the prevalence and determinants of three main states of people’s willingness to be vaccinated (WTBV) against COVID-19 – willin…
|
|
Scooped by
HAS-veille
August 7, 2023 4:15 AM
|
|
|
Scooped by
HAS-veille
August 7, 2023 3:56 AM
|
Human papillomavirus (HPV) vaccines work by preventing infections prior to natural exposure. Thus, it is likely more effective at younger ages, and it is important to understand how effectivenes
|
|
Scooped by
HAS-veille
August 7, 2023 3:42 AM
|
This report describes respiratory syncytial virus (RSV) vaccine recommendations for adults 60 years and older.
|
|
Scooped by
HAS-veille
July 12, 2023 9:56 AM
|
Background and Objective In Germany, influenza vaccination is mainly advised for persons aged 60 years and over and individuals with health risks. Since 2021, an inactivated, quadrivalent high-dose influenza vaccine (IIV4-HD) has been recommended for persons aged 60 years and over. The aim of this study was to calculate the impact of vaccinating the German population aged 60 years and over with IIV4-HD compared to standard-dose influenza vaccines (IIV4-SD) with regard to health outcomes and costs. Methods An age-stratified deterministic compartment model was built to simulate the course of influenza infection for the German population in the season 2019/20. Probabilities for health outcomes and cost data were searched from the literature and were used to compare the influenza-related health and economic effects for different scenarios. Perspectives were those of the statutory health insurance and the society. Deterministic sensitivity analyses were conducted. Results From the statutory health insurance perspective, vaccinating the German population aged 60 years and over with IIV4-HD would have prevented 277,026 infections (− 1.1%) with an increase of overall direct costs of €224 million (+ 40.1%) compared with IIV4-SD. A separate analysis showed that increased vaccination of 75% (World Health Organization recommendation for older age groups) in persons aged 60 years and over using IIV4-SD only would prevent 1,289,648 infections (− 5.1%) and would save costs from a statutory health insurance perspective of €103 million (− 13.2%) compared with IIV4-HD at actual vaccination rates. Conclusions The modeling approach offers important insights into the epidemiological and budgetary impact of different vaccination scenarios. Achieving a higher vaccination coverage with IIV4-SD in persons aged 60 years and over would result in lower costs and fewer influenza infections compared with the scenario with IIV4-HD and actual vaccination rates.
|
|
Scooped by
HAS-veille
July 11, 2023 2:00 AM
|
We numerically simulated the spread of disease for a Susceptible-Infected-Recovered (SIR) model on contact networks drawn from a small-world ensemble. We investigated the impact of two types of vaccination strategies, namely random vaccination and high-degree heuristics, on the probability density function (pdf) of the cumulative number C of infected people over a large range of its support. To obtain the pdf even in the range of probabilities as small as 10−80, we applied a large-deviation approach, in particular the 1/t Wang-Landau algorithm. To study the size-dependence of the pdfs within the framework of large-deviation theory, we analyzed the empirical rate function. To find out how typical as well as extreme mild or extreme severe infection courses arise, we investigated the structures of the time series conditioned to the observed values of C.
|
|
Scooped by
HAS-veille
July 6, 2023 3:25 AM
|
Lyme borreliosis, potentially associated with serious long-term complications, is caused by the species complex Borrelia burgdorferi sensu lato. We in…
|
|
Scooped by
HAS-veille
June 29, 2023 10:27 AM
|
CDC public health news, press releases, government public health news, medical and disease news, story ideas, photos.
|
|
Scooped by
HAS-veille
June 29, 2023 4:15 AM
|
Hot on the heels of the first approved vaccine for malaria, researchers are racing to develop even better shots that tackle the parasite at every stage of its life cycle.
|
|
Scooped by
HAS-veille
June 29, 2023 3:51 AM
|
Zika virus infection is a threat to at-risk populations, causing major birth defects and serious neurological complications. Development of a safe and…
|
|
|
Scooped by
HAS-veille
August 7, 2023 4:51 AM
|
This cohort study evaluated the protection against symptomatic Omicron BA.5 infection conferred by the Pfizer-BioNTech Original/BA.4-5 bivalent vaccin…
|
|
Scooped by
HAS-veille
August 7, 2023 4:47 AM
|
This systemic review aimed to evaluate the effectiveness of interventions for increasing the uptake of immunisation in healthcare workers (HCWs) compa…
|
|
Scooped by
HAS-veille
August 7, 2023 4:28 AM
|
This systematic review presents cost-effectiveness studies of rotavirus vaccination in high-income settings based on dynamic transmission modelling to…
|
|
Scooped by
HAS-veille
August 7, 2023 4:19 AM
|
WHO recommends at least 95% population coverage with two doses of measles-containing vaccine (MCV). Most countries worldwide use routine services to o…
|
|
Scooped by
HAS-veille
August 7, 2023 4:00 AM
|
|
|
Scooped by
HAS-veille
August 7, 2023 3:54 AM
|
Seasonal influenza vaccination coverage levels remain too low in many countries.This study aimed to evaluate the impact of a reminder letter from their general practitioner (GP) on patients
|
|
Scooped by
HAS-veille
July 13, 2023 3:23 AM
|
Existing ethics guidance and regulatory requirements emphasize the need for pregnancy-specific safety and efficacy data during the development of vacc…
|
|
Scooped by
HAS-veille
July 11, 2023 10:14 AM
|
Click on the article title to read more.
|
|
Scooped by
HAS-veille
July 7, 2023 12:50 AM
|
This report describes the percentage of countries that provided all eight World Health Organization-recommended new and underutilized vaccines in their immunization schedules.
|
|
Scooped by
HAS-veille
July 4, 2023 10:27 AM
|
It is widely argued that the value of meningococcal vaccination extends beyond the narrow value elements traditionally considered in health technology…
|
|
Scooped by
HAS-veille
June 29, 2023 4:16 AM
|
Vaccinologist Arturo Reyes-Sandoval explains how researchers are edging closer to a much-needed vaccine.
|
|
Scooped by
HAS-veille
June 29, 2023 4:13 AM
|
The candidate is moving to long-awaited phase III trials — if successful, it would be the first new jab against the disease in more than 100 years.
|
Scoop.it!
